Table 4.
Antibiotic prescribing according to indications
| Antibiotics | CAI, n (%) | HAI, n (%) | SP, n (%) | MP, n (%) | Others, n (%) |
|---|---|---|---|---|---|
| Amikacin | 1 (0.6) | ||||
| Gentamicin | 19 (11.2) | 6 (14.3) | 14 (6.9) | 15 (22.1) | 3 (4.7) |
| Amoxicillin | 3 (1.8) | 1 (0.5) | 1 (1.5) | 2 (3.1) | |
| Amoxicillin/clavulanate | 12 (7.1) | 4 (9.5) | 7 (3.4) | 2 (2.9) | 4 (6.3) |
| Ampicillin | 1 (0.6) | 8 (11.8) | 1 (1.6) | ||
| Ampicillin/cloxacillin | 1 (0.6) | 2 (4.8) | 2 (1.0) | 1 (1.6) | |
| Penicillin | 1 (0.6) | 1 (1.6) | |||
| Cefuroxime | 27 (16.0) | 5 (11.9) | 52 (50) | 5 (7.4) | 13 (20.3) |
| Cefixime | 3 (1.8) | 2 (4.8) | 1 (0.5) | 1 (1.6) | |
| Cefixime/clavulanate | 1 (0.6) | ||||
| Cefotaxime | 2 (1.0) | ||||
| Ceftriaxone | 26 (15.4) | 3 (7.1) | 25 (12.6) | 11 (16.2) | 11 (17.2) |
| Ceftriaxone/sulbactam | 2 (1.0) | ||||
| Ceftazidime | 2 (1.2) | 3 (7.1) | 3 (1.5) | 3 (4.4) | 1 (1.6) |
| Cefpodoxime | 1 (0.6) | 2 (4.8) | 1 (0.5) | 1 (1.6) | |
| Cefepime | 1 (0.6) | ||||
| Azithromycin | 5 (3.0) | 2 (3.1) | |||
| Erythromycin | 3 (1.8) | ||||
| Clarithromycin | 3 (1.8) | ||||
| Ciprofloxacin | 13 (7.7) | 4 (9.5) | 22 (10.8) | 12 (17.6) | 6 (9.4) |
| Levofloxacin | 1 (0.6) | 2 (1.0) | 1 (1.6) | ||
| Clindamycin | 1 (0.6) | 1 (0.5) | |||
| Imipenem | 1 (2.4) | ||||
| Meropenem | 1 (0.6) | 1 (2.4) | 1 (0.5) | 1 (1.5) | |
| Metronidazole | 36 (21.3) | 7 (16.7) | 68 (33.3) | 7 (10.2) | 16 (25.0) |
| Nitrofurantoin | 2 (1.2) | ||||
| Doxycycline | 1 (2.4) | ||||
| Trimethoprim/sulfamethoxazole | 1 (0.6) | ||||
| Vancomycin | 4 (2.4) | 1 (2.4) | 3 (4.4) | ||
| Total | 169 (30.0) | 42 (7.4) | 204 (36.2) | 68 (12.1) | 64 (11.3) |
CAI – community-acquired infection; HAI – healthcare-associated infection; MP – medical prophylaxis; SP – surgical prophylaxis.